20-35287167-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178468.6(FAM83C):c.1612G>A(p.Glu538Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 1,606,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178468.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM83C | NM_178468.6 | c.1612G>A | p.Glu538Lys | missense_variant | 4/4 | ENST00000374408.4 | NP_848563.1 | |
FAM83C | XM_047439892.1 | c.1084G>A | p.Glu362Lys | missense_variant | 4/4 | XP_047295848.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM83C | ENST00000374408.4 | c.1612G>A | p.Glu538Lys | missense_variant | 4/4 | 1 | NM_178468.6 | ENSP00000363529.3 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152172Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000248 AC: 60AN: 241542Hom.: 0 AF XY: 0.000220 AC XY: 29AN XY: 132100
GnomAD4 exome AF: 0.000217 AC: 315AN: 1454480Hom.: 0 Cov.: 34 AF XY: 0.000187 AC XY: 135AN XY: 723810
GnomAD4 genome AF: 0.000171 AC: 26AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 06, 2023 | The c.1612G>A (p.E538K) alteration is located in exon 4 (coding exon 4) of the FAM83C gene. This alteration results from a G to A substitution at nucleotide position 1612, causing the glutamic acid (E) at amino acid position 538 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at